Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|October 1, 1989
Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex virusesM N Ellis, D C Lobe, T SpectorAntiviral Research|February 1, 1991
Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in miceD C Lobe, T Spector, M N EllisAntiviral Research|December 24, 1998
Therapeutic evaluation of compounds in the SCID-RA papillomavirus modelD C Lobe, J W Kreider, W C PhelpsAntiviral Chemistry & Chemotherapy|January 6, 1999
Molecular targets for human papillomaviruses: prospects for antiviral therapyW C Phelps, J A Barnes, D C LobeAntimicrobial Agents and Chemotherapy|May 1, 1992
Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovirT Spector, D C Lobe, M N Ellis, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1986
Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude miceM N Ellis, J L Martin, D C Lobe, et al.Antimicrobial Agents and Chemotherapy|March 1, 1989
Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1M N Ellis, R Waters, E L Hill, et al.Applied and Environmental Microbiology|June 1, 1985
UV inactivation of pathogenic and indicator microorganismsJ C Chang, S F Ossoff, D C Lobe, et al.Virology|May 4, 2000
The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificityE P Dixon, G L Pahel, W J Rocque, et al.Protein Expression and Purification|February 25, 2000
Replication-associated activities of purified human papillomavirus type 11 E1 helicaseW J Rocque, D J Porter, J A Barnes, et al.Pageof 1